CGEM

10.16

1.70% 0.17

Handel nachbörslich: 10.16

Cullinan Therapeutics Inc (CGEM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$9.99

Offen:

$9.87

24-Stunden-Volumen:

621.95K

Relative Volume:

0.50

Marktkapitalisierung:

$600.21M

Einnahmen:

Nettoeinkommen (Verlust:

$-153.16M

KGV:

-2.7534

EPS:

-3.69

Netto-Cashflow:

$-134.48M

1W Leistung:

+2.42%

1M Leistung:

-4.06%

6M Leistung:

+30.09%

1J Leistung:

-13.75%

1-Tages-Spanne:

$9.78

$10.25

1-Wochen-Bereich:

$9.41

$10.70

52-Wochen-Spanne:

$5.68

$13.33

Cullinan Therapeutics Inc Stock (CGEM) Company Profile

Firmenname

Cullinan Therapeutics Inc

Sektor

Healthcare (1114)

Branche

Biotechnology (625)

Telefon

617-410-4650

Adresse

ONE MAIN STREET, CAMBRIDGE

Mitarbeiter

111

Twitter

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

CGEM's Discussions on Twitter

Vergleichen Sie CGEM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CGEM Cullinan Therapeutics Inc	10.16	590.17M	0	-153.16M	-134.48M	-3.69
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-21	Fortgesetzt	H.C. Wainwright	Buy
2025-06-11	Fortgesetzt	Stifel	Buy
2024-10-24	Eingeleitet	UBS	Buy
2024-05-01	Eingeleitet	Stifel	Buy
2024-04-15	Eingeleitet	William Blair	Outperform
2024-02-15	Eingeleitet	Wedbush	Outperform
2023-06-15	Eingeleitet	TD Cowen	Outperform
2022-11-21	Eingeleitet	BTIG Research	Buy
2021-04-27	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-02-02	Eingeleitet	Evercore ISI	Outperform
2021-02-02	Eingeleitet	Morgan Stanley	Equal-Weight
2021-02-02	Eingeleitet	SVB Leerink	Outperform
2021-02-01	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten

Dec 31, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 3.9%What's Next? - MarketBeat

Dec 31, 2025

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Dec 31, 2025

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 31, 2025

Dec 29, 2025

Nadim Ahmed Sells 9,922 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Dec 29, 2025

Dec 25, 2025

Assenagon Asset Management S.A. Has $1.05 Million Stake in Cullinan Therapeutics, Inc. $CGEM - MarketBeat

Dec 25, 2025

Dec 23, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap DownTime to Sell? - MarketBeat

Dec 23, 2025

Dec 22, 2025

Insider Sell: Jennifer Michaelson Sells Shares of Cullinan Thera - GuruFocus

Dec 22, 2025

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $13,463.45 in Stock - MarketBeat

Dec 22, 2025

Cullinan Therapeutics CSO Sells Shares - TradingView — Track All Markets

Dec 22, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $28,023.66 in Stock - Defense World

Dec 22, 2025

Dec 21, 2025

Cullinan Therapeutics (CGEM) Price Target Increased by 19.75% to 32.84 - Nasdaq

Dec 21, 2025

Will Cullinan Therapeutics Inc. stock deliver shareholder value2025 Price Targets & Weekly High Potential Stock Alerts - ulpravda.ru

Dec 21, 2025

Dec 20, 2025

Cullinan Therapeutics price target raised to $34 from $25 at Wedbush - MSN

Dec 20, 2025

Cullinan Therapeutics Earnings Notes - Trefis

Dec 20, 2025

Cullinan Therapeutics shows rising price performance with jump to 93 RS rating - MSN

Dec 20, 2025

Dec 19, 2025

Is Cullinan Therapeutics Inc. stock a contrarian buy2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - Улправда

Dec 19, 2025

Jacquelyn Sumer Sells 3,480 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Dec 19, 2025

Jeffrey Alan Jones Sells 4,632 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Dec 19, 2025

Cullinan Therapeutics Executives Sell Shares for Tax Obligations - TradingView — Track All Markets

Dec 19, 2025

Officer Michaelson Files To Sell 1,345 Of Cullinan Therapeutics Inc [CGEM] - TradingView — Track All Markets

Dec 19, 2025

How Cullinan Therapeutics Inc. stock reacts to inflationary pressures2025 Sector Review & Reliable Intraday Trade Plans - Улправда

Dec 19, 2025

Jobs Data: Will Cullinan Therapeutics Inc. stock deliver better than expected guidanceMarket Trend Summary & Technical Buy Zone Confirmations - Улправда

Dec 19, 2025

Dec 18, 2025

Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and Cullinan Management (CGEM) - The Globe and Mail

Dec 18, 2025

Dec 17, 2025

Will Cullinan Therapeutics (NASDAQ:CGEM) Spend Its Cash Wisely? - Yahoo Finance

Dec 17, 2025

Cowen reiterates Buy rating on Cullinan Oncology stock after ASH data - Investing.com Nigeria

Dec 17, 2025

Dec 16, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 2,148 Shares of Stock - MarketBeat

Dec 16, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 995 Shares - MarketBeat

Dec 16, 2025

Cullinan Therapeutics (CGEM) Jumps on Promising Phase 1 Data for CLN-049 in AML, Showing Strong Response Rates - Finviz

Dec 16, 2025

Dec 15, 2025